WO2016037588A3 - 用于合成抗艾滋病药物增强剂cobicistat的中间体 - Google Patents

用于合成抗艾滋病药物增强剂cobicistat的中间体 Download PDF

Info

Publication number
WO2016037588A3
WO2016037588A3 PCT/CN2015/089406 CN2015089406W WO2016037588A3 WO 2016037588 A3 WO2016037588 A3 WO 2016037588A3 CN 2015089406 W CN2015089406 W CN 2015089406W WO 2016037588 A3 WO2016037588 A3 WO 2016037588A3
Authority
WO
WIPO (PCT)
Prior art keywords
cobicistat
synthesis
aids drug
drug enhancer
disclosed
Prior art date
Application number
PCT/CN2015/089406
Other languages
English (en)
French (fr)
Other versions
WO2016037588A2 (zh
Inventor
李昌龙
楼科侠
喻立煌
徐帅
张达
Original Assignee
宁波九胜创新医药科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 宁波九胜创新医药科技有限公司 filed Critical 宁波九胜创新医药科技有限公司
Publication of WO2016037588A2 publication Critical patent/WO2016037588A2/zh
Publication of WO2016037588A3 publication Critical patent/WO2016037588A3/zh

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

提供一种用于合成抗艾滋病药物增强剂cobicistat的中间体化合物I及其合成方法。还提供用该化合物I合成 (2R, 5R)-1, 6-二苯基-2, 5-己二胺的方法，该方法步骤短、条件简单易操作，生产成本低，且产品纯度高。
PCT/CN2015/089406 2014-09-12 2015-09-11 用于合成抗艾滋病药物增强剂cobicistat的新中间体 WO2016037588A2 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410466139.5 2014-09-12
CN201410466139.5A CN104193643B (zh) 2014-09-12 2014-09-12 用于合成抗艾滋病药物增强剂cobicistat的中间体

Publications (2)

Publication Number Publication Date
WO2016037588A2 WO2016037588A2 (zh) 2016-03-17
WO2016037588A3 true WO2016037588A3 (zh) 2016-05-26

Family

ID=52079055

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/089406 WO2016037588A2 (zh) 2014-09-12 2015-09-11 用于合成抗艾滋病药物增强剂cobicistat的新中间体

Country Status (2)

Country Link
CN (1) CN104193643B (zh)
WO (1) WO2016037588A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104193643B (zh) * 2014-09-12 2016-02-10 宁波九胜创新医药科技有限公司 用于合成抗艾滋病药物增强剂cobicistat的中间体
CN105017082B (zh) * 2015-07-31 2017-09-19 上海皓元医药股份有限公司 一种心衰药Entresto 关键中间体(R)‑叔丁基 (1‑([1,1`‑联苯]‑4‑基)‑3‑羟基丙烷‑2‑基)氨基甲酸酯的制备方法
CN109912426B (zh) * 2017-12-13 2023-01-13 上海奥博生物医药股份有限公司 用于合成抗艾滋病药物增强剂可比司他(cobicistant)的中间体

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012045007A1 (en) * 2010-10-01 2012-04-05 Gilead Sciences, Inc. Method of preparation of (4 - {4 -acetylamino- 2 - [3- ( 2 - isopropyl - thiazol - 4 - ylmethyl) - 3 -methyl - ureido] - butyryl amino} -1 -benzyl- 5 -phenyl- pentyl) -carbamic acid thiazol - 5 - ylmethyl ester
CN102438982A (zh) * 2009-04-03 2012-05-02 吉里德科学公司 用于制备细胞色素p450单加氧酶抑制剂的方法和所涉及的中间体
WO2013116715A1 (en) * 2012-02-03 2013-08-08 Gilead Sciences, Inc. Methods and intermediates for preparing pharmaceutical agents
US20140051888A1 (en) * 2012-08-20 2014-02-20 Ampac Fine Chemicals Llc Novel stereoisomeric mixtures, synthesis and uses thereof
CN104193643A (zh) * 2014-09-12 2014-12-10 宁波九胜创新医药科技有限公司 用于合成抗艾滋病药物增强剂cobicistat的新中间体

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102438982A (zh) * 2009-04-03 2012-05-02 吉里德科学公司 用于制备细胞色素p450单加氧酶抑制剂的方法和所涉及的中间体
WO2012045007A1 (en) * 2010-10-01 2012-04-05 Gilead Sciences, Inc. Method of preparation of (4 - {4 -acetylamino- 2 - [3- ( 2 - isopropyl - thiazol - 4 - ylmethyl) - 3 -methyl - ureido] - butyryl amino} -1 -benzyl- 5 -phenyl- pentyl) -carbamic acid thiazol - 5 - ylmethyl ester
WO2013116715A1 (en) * 2012-02-03 2013-08-08 Gilead Sciences, Inc. Methods and intermediates for preparing pharmaceutical agents
US20140051888A1 (en) * 2012-08-20 2014-02-20 Ampac Fine Chemicals Llc Novel stereoisomeric mixtures, synthesis and uses thereof
CN104193643A (zh) * 2014-09-12 2014-12-10 宁波九胜创新医药科技有限公司 用于合成抗艾滋病药物增强剂cobicistat的新中间体

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
XU, LIANHONG ET AL.: "A Novel and Efficient Synthesis of Chiral C2-Symmetric 1, 4-Diamines", TETRAHEDRON LETTERS, vol. 50, no. 5, 24 November 2008 (2008-11-24), pages 552 - 554, XP025799917, DOI: doi:10.1016/j.tetlet.2008.11.071 *
XU, LIANHONG ET AL.: "Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer", ACS MEDICINAL CHEMISTRY LETTERS, vol. 1, no. 5, 17 May 2010 (2010-05-17), pages 209 - 213, XP009156835, DOI: doi:10.1021/ml1000257 *

Also Published As

Publication number Publication date
WO2016037588A2 (zh) 2016-03-17
CN104193643B (zh) 2016-02-10
CN104193643A (zh) 2014-12-10

Similar Documents

Publication Publication Date Title
WO2015145415A3 (en) Ibrutinib solid forms and production process therefor
MX2018002402A (es) Compuestos de heteroarilo o arilo biciclicos fusionados como moduladores de la quinasa 4 asociada al receptor de la interleucina 1 (irak4).
WO2015110897A3 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
WO2016007617A3 (en) Pharmaceutical compounding kit
MX2011008946A (es) Un complejo de haluro de hidrogeno de agomelatina y la preparacion del mismo.
MX2019003818A (es) Metodo para la sintesis de derivado de 3-fenil-2,3,4,8,9,10-hexahi dropiran [2,3-f] cromeno e isomero optico del mismo.
MY181641A (en) Amino pyran ring derivative and composition and use thereof
WO2016100732A3 (en) Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives
WO2016179184A3 (en) Enantioselective syntheses of heteroyohimbine natural product intermediates
WO2016207914A3 (en) Methods for preparing oltipraz
WO2015159275A3 (en) An improved process for the preparation of rifamycin derivatives
WO2016024286A3 (en) An improved process for synthesis of lenalidomide
WO2017205964A8 (en) Aminosteroid derivatives and process for producing same
WO2016037588A3 (zh) 用于合成抗艾滋病药物增强剂cobicistat的中间体
WO2015120111A3 (en) Expedient synthesis of sitagliptin
WO2015181802A3 (en) Oral pharmaceutical composition of isotretinoin
WO2016056022A3 (en) Intermediates and processes to prepare anidulafungin
WO2016056023A3 (en) Intermediates and processes to prepare micafungin
WO2017098533A3 (en) Process for preparation of lisdexamphetamine
WO2017056013A3 (en) Modified wood product and a process for producing said product
WO2016014864A8 (en) Hydroxy-(r),(r)-2,2'-bismethylnaltrexones and uses thereof
EP3658553A4 (en) NEW INTERMEDIATE PRODUCTS FOR THE SYNTHESIS OF AMINOPYRIMIDE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PROCESS FOR THE PRODUCTION OF AMINOPYRIMIDE DERIVATIVES USING THE SAME
WO2015087343A3 (en) An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof
WO2017214423A3 (en) Derivatives of thailanstatin a, methods of treatment and methods of synthesis thereof
WO2017046816A3 (en) Process for the preparation of derivatives of benzodioxole

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15840197

Country of ref document: EP

Kind code of ref document: A2